Selected aspects of allergy nursing
DOI:
https://doi.org/10.2478/pielxxiw-2020-0013Keywords:
allergy, medical records, allergen-specific immunotherapy, allergy nursing, skin prick testAbstract
SELECTED ASPECTS OF ALLERGY NURSING
Introduction. Due to their dynamic character, allergic conditions pose challenges for modern medicine and constitute a public health problem. Nearly 40% of the general Polish population is estimated to suffer from an allergy. We would like to emphasize that allergies are not some extraordinary ailments; instead, they commonly coincide with or are complications of other systemic conditions. Hence, national health policies should prioritize the development and implementation of ready-to-use protocols that focus mainly on prevention rather than treatment.
Conclusions. In an outpatient setting the care for individuals who suffer from allergies is facilitated by therapeutic teams. Allergy nurses play a special role in this framework, with the scope of their professional duties including diagnostic procedures, treatment, being a mediator for patient education initiated by the therapeutic team. This article focuses on three important types of allergy nurses‘ responsibilities: diagnostic procedures (e.g. skin prick tests), therapeutic procedures (allergen-specific immunotherapy), and selected aspects of medical record-keeping
References
1. Sybilski AJ, Raciborski F, Lipiec A, et al. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study. Postępy Dermatol Alergol. 2015;32(1):1-10.
2. Odhiambo JA, Williams HC, Clayton TO, et al. ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251-1258.
3. Samoliński B, Raciborski F, Lipiec A, et al. Epidemiology of allergic diseases in Poland. Pol J Allergol. 2014;1:10-8.
4. DuBuske L. Appropriate and inappropriate use of immunotherapy. Ann Allergy Asthma Immunol 2001; 87(Suppl): 56-67.
5. Joint Task Force on Practice Parameters: Allergen immunotherapy: a practice parameter. Ann. Allergy Asthma Immunol. 2003; 90:1-40.
6. Jutel M, Kowalski ML, Rogala B, et al. Swoista immunoterapia alergenowa. (w) Standardy w alergologii. Cz. I. Kruszewski J, Kowalski ML (red.). Kraków: Medycyna Praktyczna, wyd. II, 2010; 152-159.
7. Kowalski ML, Buczyłko K, Jurkiewicz D, et al. Objawy niepożądane w przebiegu immunoterapii przedsezonowej preparatem Pollinex®+Rye u pacjentów uczulonych na pyłki drzew i/lub traw – badanie wieloośrodkowe. Alergia Astma Immunol. 2001; 6(1): 45-50.
8. Kowalski ML, Jutel M. Mechanisms of specific immunotherapy of allergic diseases. Allergy. 1998; 52: 485-492.
9. Kowalski ML. Systemic and specific treatment for a global disease: alergen immunotherapy revisited. Allergy 2006; 61(7): 791-795.
10. Kruszewski J (red.) Anafilaksja. Medycyna Praktyczna. Kraków, 2009.
11. Fujita H, Soyka MB, Akdis CA. Mechanisms of alergen-specific immunotherapy. Clin Transl Allergy. 2012; 2(1): 2.
12. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical alergen-specific immunotherapy. Allergy 2006; 61 (Suppl. 82): 1-201.
13. Eifan AO, Shamji MH, Durham SR. Long-term clinical and immunological effects of alergen immunotherapy. Curr Opin Allergy Clin Immunol 2011; 11(6): 586-593.
14. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43: 523.
15. Rogala B. Risk and safety of immunotherapy. Allergy 1998; 53: 474-478.
16. Buczyłko K, Chwała C, Wagner A, et al. Porównanie klinicznej skuteczności całorocznego przedsezonowego odczulania alergii na pyłki traw preparatem Catalet T. Alergia Astma Immunol. 2000; 5(3): 183-187.
17. Copenhaver CC, Parker A, Patch S. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Ann Allergy Asthma Immunol. 2011; 107(5): 441-445.
18. Zuberbier T, Bachert C, Bousquet PJ, et al. GA2LEN/EAACI pocketguide for alergen-specific immunotherapy for allergic rhinitic and asthma. Allergy 2010; 65: 1525-1530.
19. Światowa strategia rozpoznawania, leczenia i prewencji astmy. Raport NHLBI/WHO. Med. Prakt 2002; 6: 1-181.
20. Passalacgua G, Duhram S. Specific Immunotherapy. J. Allergy Clin. Immunol. 2007; 119: 881-891.
21. Chyrek-Borowska S. Groźne dla życia objawy ogólne i narządowe w przebiegu immunoterapii swoistej i testów skórnych. [w] Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 92-98.
22. Kruszewski J. Wstrząs anafilaktyczny. (w) Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 78-86.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
